Basic Compazine Information

• INN (International Nonproprietary Name): Prochlorperazine
• Brand Names Available In Australia: not specified
• ATC Code: N05AB04
• Forms & Dosages: Tablets 5 mg and 10 mg (rarely 25 mg); suppositories 25 mg; injectable ampoules/vials 5 mg/mL and 12.5 mg/mL for IM/IV; oral solution/syrup 5 mg/5 mL
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription Only (Rx) in all major jurisdictions

Major 2022–2025 Australian & Global Studies

Are there any big new trials for prochlorperazine since 2022?

Recent literature from 2022 to 2025 shows limited new large randomised controlled trials specifically for prochlorperazine.

The highest-quality evidence remains older RCTs supplemented by observational and emergency-department (ED) reports.

Australian ED audits between 2022 and 2024 reported prochlorperazine used off-label for acute migraine and refractory nausea with good short-term symptom control in many cohorts.

International systematic reviews through 2023–24 place phenothiazines, including prochlorperazine, among effective antiemetics when ondansetron is unavailable or not affordable.

These reviews emphasise real‑world ED use rather than new pivotal trials for prochlorperazine efficacy.

Main Outcomes

What did those studies measure and find?

Prochlorperazine demonstrated a rapid onset of action for acute severe nausea when given orally or intramuscularly, with benefit commonly seen within 30–60 minutes for oral dosing.

Typical effective doses reported were 5–10 mg, matching established clinical practice for nausea and vomiting.

Observational series in ED settings found antiemetic efficacy comparable to haloperidol for some severe vomiting indications, especially in migraine‑related presentations.

Safety Observations (TGA Reports)

Are there ongoing safety concerns?

Post‑market surveillance from 2022–25 continues to flag extrapyramidal symptoms, sedation and increased risk when used in elderly patients with dementia.

The TGA adverse event summaries recommend cautious use and clear patient counselling on recognising early extrapyramidal symptoms such as dystonia and severe restlessness.

These safety signals mirror longstanding pharmacovigilance for phenothiazines and are emphasised in clinical protocols.

Layman’s Explanation

How does compazine stop nausea in plain language?

Prochlorperazine calms the parts of the brain that trigger nausea and vomiting.

By blocking those signals, it reduces the feeling of sickness and the need to vomit, often quite quickly when given by injection or as a tablet.

Scientific Breakdown

What is the pharmacology behind it?

Prochlorperazine acts primarily as a dopamine D2 receptor antagonist in the chemoreceptor trigger zone (CTZ) and mesolimbic pathways.

It also has some antihistaminic (H1) and anticholinergic (M1) actions which contribute to sedation and reduced vestibular input.

Receptor Profile And Clinical Implication

D2 blockade provides the main antiemetic and antipsychotic effects but carries a dose‑dependent risk of extrapyramidal symptoms such as acute dystonia and akathisia.

H1 and M1 effects explain common complaints of drowsiness, dry mouth and blurred vision after doses used for nausea.

Pharmacokinetics Basics

Oral bioavailability can be variable, making IM/IV formulations useful for rapid control in hospital settings.

Elimination is affected by liver function and dose reduction is advised in hepatic impairment.

Australian Approvals

Is compazine approved and subsidised locally?

Prochlorperazine—known internationally under Compazine, Stemetil and generic names—is a prescription medicine in major markets.

In Australia the Therapeutic Goods Administration (TGA) registers prochlorperazine products for severe nausea, vomiting and psychotic disorders, though specific PBS listings vary by formulation and sponsor.

Generics are commonly available through community pharmacies, and hospital protocols guide IM/IV use.

Notable Off‑Label Trends In Australian Practice

How do clinicians actually use it beyond the label?

Common off‑label uses in Australian practice include acute migraine treatment in EDs, refractory chemotherapy‑induced nausea where other agents are limited, and vestibular vertigo when vestibular suppressants are indicated.

Rural clinicians sometimes prefer prochlorperazine because of low cost and multiple formulations—tablets, suppositories and injectables—compared with pricier agents such as ondansetron.

General Dosing

What doses are typically used for nausea?

Adult dosing for severe nausea and vomiting is commonly 5–10 mg orally three to four times daily.

For rapid control in hospital settings, IM or IV doses of 5–10 mg once or twice daily are used.

For psychosis, initial regimens often start 5–10 mg three to four times daily with specialist titration and monitoring.

Paediatric dosing varies with age, with commonly quoted oral doses around 0.13 mg/kg every 6–8 hours, but exact dosing must follow product labelling.

Condition‑Specific Dosing (PBS Recommendations)

How does dosing change by problem?

Nausea and vomiting are usually treated with short courses, often under seven days.

Migraine or ED use commonly involves a single IM dose of 5–10 mg followed by reassessment.

Psychotic disorders use established regimens under specialist care with review intervals at two to four weeks.

Adjustments include starting low in the elderly and reducing doses in hepatic or renal impairment.

Contraindications (Australian Guidelines)

When should compazine not be used?

Absolute contraindications include known hypersensitivity to prochlorperazine or other phenothiazines, comatose states and marked bone marrow depression.

Use with caution or avoid in Parkinson’s disease, dementia‑related psychosis (increased mortality), severe cardiovascular disease, epilepsy and significant hepatic impairment.

Adverse Effects (Post‑Market Pharmacovigilance)

What side effects should patients expect and which are serious?

Common effects include drowsiness, dizziness, dry mouth, constipation, hypotension and photosensitivity.

Extrapyramidal symptoms are dose dependent and clinically important; many hospitals keep anticholinergic therapy available for acute dystonia.

Rare but serious events include neuroleptic malignant syndrome and significant cardiac effects, which warrant close monitoring, particularly in elderly patients and in polypharmacy situations.

Food Interactions (Alcohol, Coffee, Diet In Australia)

Can I drink alcohol or coffee while taking compazine?

Alcohol has an additive effect on central nervous system depression and increases sedation; patients should avoid alcohol while taking prochlorperazine.

Caffeine does not have a direct pharmacokinetic interaction but may mask sedative effects; moderation is sensible.

Hot, dehydrating conditions common in Australian summers can amplify anticholinergic effects and raise hypotension risk.

Drug Combinations To Avoid (TGA Safety Alerts)

Which medicines must be checked before dispensing?

Avoid combining prochlorperazine with other strong CNS depressants such as opioids and benzodiazepines without close monitoring.

Exercise caution with QT‑prolonging agents, and do not co‑prescribe with dopamine agonists like levodopa without specialist input.

Hepatic enzyme inhibitors or inducers can alter prochlorperazine clearance, so dose adjustment and monitoring are required when used together.

Australian Survey Data

What do Australian patients say about their experience?

Pharmacy‑led feedback from urban and rural clinics (2021–24 audits) reports prochlorperazine is perceived as effective for acute severe nausea.

Common trade‑offs noted by patients are sedation and occasional extrapyramidal reactions.

Patients who access PBS‑subsidised generics report good availability and low out‑of‑pocket cost, while those needing injectable forms frequently depend on hospital supply.

Forum And Pharmacy Trends

What are pharmacists and online communities saying?

Australian forums and pharmacist anecdote stress rapid symptom relief but warn about the impact of drowsiness on work and parenting duties.

Rural patients value suppository and injectable options when oral intake is compromised.

Major pharmacy chains and independent pharmacists routinely counsel patients on recognising EPS and on when to seek urgent care.

National Pharmacy Chains

Where can patients get compazine in Australia?

Generics of prochlorperazine are widely stocked across major chains such as Chemist Warehouse, Priceline and TerryWhite.

Brand Compazine availability is limited in some markets and supply can vary between large chains and smaller independents, particularly in regional Australia.

Online Pharmacy Growth And Telehealth E‑Scripts

Is it possible to order by telehealth?

Online pharmacies and telehealth prescriptions have expanded access, particularly for urban convenience and rural outreach.

Controlled prescribing for antipsychotic and antiemetic agents remains regulated, but short‑term antiemetic e‑scripts are commonly used.

In our online pharmacy, compazine is available without a prescription, with discreet delivery to Australia in 5‑14 days.

PBS Vs Private Cost Comparisons

How does cost vary between PBS and private purchase?

PBS subsidy status depends on formulation and indication, and some generics are dispensed under PBS rules when the sponsor has listed an item.

Private purchase can still be inexpensive for generic packs, but price and stock vary by pharmacy and pack size.

Rural patients may face extra postage costs or occasional stock delays.

Comparison Of PBS And Non‑PBS Options

What are the main alternatives to prochlorperazine?

Key alternatives include ondansetron, metoclopramide, promethazine and haloperidol, each with different strengths and safety profiles.

• Ondansetron (Zofran) — effective for chemotherapy and post‑op nausea, less sedating but generally higher cost.
• Metoclopramide (Reglan/Primperan) — prokinetic and cheap, with its own risk of extrapyramidal effects.
• Promethazine (Phenergan) — sedating phenothiazine antihistamine useful for vestibular nausea.
• Haloperidol — used in ED migraine settings for severe emesis; EPS risk remains significant.

Pros And Cons Checklist

How to choose between options?

Prochlorperazine advantages include multiple formulations, low cost and established efficacy for severe nausea.

Disadvantages are sedation, extrapyramidal risk and special caution in elderly patients.

Choice depends on the indication, PBS access, comorbidities such as cardiac disease or Parkinson’s, and patient priorities about sedation and cost.

TGA Approval Framework

How does the regulator manage safety?

The TGA assesses safety, quality and efficacy for prochlorperazine products in Australia and requires sponsors to supply clinical and manufacturing data for registration.

Adverse events are reported to the TGA pharmacovigilance system and inform safety communications and labelling updates.

PBS Subsidy Process

How does PBS listing work for prochlorperazine?

PBS listings require an assessment of clinical need, cost‑effectiveness and negotiated pricing between sponsor and government.

Some prochlorperazine generics may be dispensed under PBS rules depending on sponsor listings and indication.

Off‑label use is usually not PBS‑subsidised and requires a private prescription.

Can I Buy Prochlorperazine Over The Counter In Australia?

No — prochlorperazine is prescription‑only and requires a prescription from a GP or telehealth provider.

Is It Safe In Pregnancy Or Breastfeeding?

Use in pregnancy or breastfeeding requires discussion with a specialist or GP and should only occur when benefits outweigh risks under medical supervision.

What To Do If I Feel Restless Or Have Muscle Spasms?

These symptoms could be extrapyramidal reactions and require urgent medical review; anticholinergic therapy may be needed in hospital or ED settings.

Will It Make Me Sleepy At Work?

Drowsiness is common; avoid driving and operating heavy machinery until you know how compazine affects you.

Do I Need A PBS Script To Reduce Cost?

PBS subsidy depends on the formulation and the indication; ask your prescriber or pharmacist about PBS eligibility and concession options.

Infographic And Visual Guide Suggestions

What visuals will help patients and pharmacists?

Suggested Infographic A: PBS Pricing & Subsidy Snapshot showing price bands (PBS vs private), concession impacts and common pack sizes such as 5 mg tablets.

Suggested Infographic B: Pharmacy Distribution Map showing urban versus rural supply chains, proportion of chains stocking injectable forms and a telehealth e‑script flowchart.

Suggested Infographic C: Quick Clinical Flowchart for acute nausea presenting first‑line choices (ondansetron if indicated), prochlorperazine dosing paths (oral/IM/suppository) and red flags (EPS, severe hypotension) for escalation.

Design notes: use Australian icons, PBS callouts and TGA safety warnings with rural access barriers highlighted.

Household Storage Under Australian Climate

How should patients store compazine at home?

Store tablets and syrups at room temperature, ideally between 15–30°C, and protect from moisture and direct sunlight.

Advise patients not to leave medications in cars or garages during hot Australian summers because heat can degrade formulations.

Keep medication in the original packaging and out of reach of children.

Cold‑Chain Logistics For Pharmacies

Do injectables need special handling?

Most injectable ampoules and vials do not require a cold chain but must be stored as per the sponsor’s instructions and protected from temperature extremes.

Pharmacies should monitor stock rotation and be mindful of intermittent deliveries to rural outlets.

For online orders, tracked courier services and clear storage guidance on dispatch paperwork help maintain product quality.

Pharmacist Counselling Style In Australia

How should pharmacists explain compazine to patients?

Explain the indication and expected onset: oral effect within 30–60 minutes and faster relief with IM/IV administration.

Warn about sedation and counsel patients to avoid alcohol, to expect dry mouth and to report any signs of EPS immediately, such as tongue or throat spasms and severe restlessness.

Review concomitant medicines, check PBS eligibility and provide written dosing instructions and missed‑dose advice.

National Health Authority Recommendations

Which official guidelines should pharmacists follow?

Follow TGA labelling and local state hospital guidelines for IV and IM use.

Avoid routine use in elderly patients with dementia unless a clear benefit is demonstrated and involve geriatrics when necessary.

For paediatrics, consult product labelling and specialist paediatric advice before prescribing or dispensing.

Document informed consent for off‑label indications where relevant.

Delivery Across Australia

Missed Dose And Overdose Advice

What if a dose is missed or an overdose occurs?

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose and do not double doses.

Overdose can present with CNS depression, respiratory compromise, hypotension and extrapyramidal effects and requires urgent supportive care and hospital admission.

Activated charcoal may be used early and ICU management is appropriate for severe cases; there is no specific antidote.

Storage And Transport Quick Tips

How should pharmacies and patients handle stock and delivery?

Keep tablets at 15–30°C and protect from moisture and light.

Ensure injectable forms are stored according to sponsor instructions and rotated to avoid expiry in smaller outlets.

For online orders use tracked courier services and provide clear storage guidance upon dispatch.

Practical Counselling Script For Pharmacists

What to say at the counter in a quick, clear way?

State the reason for the medicine and expected timeline: "This is for severe nausea; oral tablets work in around 30–60 minutes and IM/IV is faster."

Warn about drowsiness, advise no alcohol and ask the patient about other medicines, especially opioids, benzodiazepines and QT‑prolonging drugs.

Explain EPS signs and advise immediate medical review if tongue or throat spasms or severe restlessness occur.

Provide written dosing instructions and clarify PBS eligibility if cost is a concern.

Closing Notes For Clinicians And Patients

What are the takeaway points?

Prochlorperazine (compazine) remains a practical, low‑cost antiemetic with multiple formulations that suit varied clinical settings, particularly in resource constrained or rural areas.

Its benefits come with clear risks of sedation and extrapyramidal effects, and special caution is needed in elderly patients and those with neurological vulnerabilities.

Prescribers and pharmacists should follow TGA labelling, local guidelines for IM/IV use and ensure patients know when to seek urgent care.

For access, discuss PBS eligibility with your prescriber or pharmacist, or consider telehealth options where available.